Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.
Texto
Imagem
Documentos relacionados
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern
To analyze and describe a series of patients with non- small cell lung cancer treated with erlotinib during a period prior to the mandatory investigation of the epidermal
cancers are categorized as small cell lung cancer, a subtype with a neuroendocrine phenotype, or non-small cell lung cancer, which comprises adenocarcinoma, squamous cell
Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de
cancers are categorized as small cell lung cancer, a subtype with a neuroendocrine phenotype, or non-small cell lung cancer, which comprises adenocarcinoma, squamous cell
Clinical outcomes and prognostic factors of patients with advanced non-small cell lung treated in clinical trials in Brazil: A single institution experience. Leite GM, França
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung
used with diffusion-weighted imaging for M-stage assessment in patients with non-small cell lung cancer (NSCLC), with an accuracy that was equivalent to that of